Showing results (121-130 of 149) with videos related to
Sort By:
Pageof 15
Contemporary Clinical Trials|July 16, 2023
Adapting a clinical decision support system to improve identification of pediatric hypertension in a rural health system: Design of a pragmatic trialCatherine P Benziger, Madison Suess, Clayton I Allen, et al.JAMA Cardiology|July 10, 2024
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Male and Female Patients: A Secondary Analysis of the ADAPTABLE Randomized Clinical TrialCatherine P Benziger, Amanda Stebbins, Lisa M Wruck, et al.Journal of the American Heart Association|June 22, 2023
Internet Versus Noninternet Participation in a Decentralized Clinical Trial: Lessons From the ADAPTABLE StudyRebecca Shen, Hillary Mulder, Lisa Wruck, et al.Journal of the American Heart Association|October 13, 2023
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients Treated With P2Y12 InhibitorsSaket Girotra, Amanda Stebbins, Lisa Wruck, et al.Journal of the Society for Cardiovascular Angiography & Interventions|April 1, 2026
Baseline ECG Outperforms the Angiogram for Predicting Mortality in COVID-19-Associated STEMI: Insights From the NACMI RegistryKevin R Bainey, Payam Dehghani, Jyotpal Singh, et al.JAMA Cardiology|July 24, 2024
Contribution of Clinical Trial Event Data by Data Source: A Prespecified Analysis of the ADAPTABLE Randomized Clinical TrialJennifer A Rymer, Hillary Mulder, Lisa M Wruck, et al.Diabetes Care|September 15, 2023
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the ADAPTABLE TrialDennis I Narcisse, Hwasoon Kim, Lisa M Wruck, et al.JAMA Cardiology|October 4, 2023
Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease: A Secondary Analysis of the ADAPTABLE Randomized Clinical TrialAmber Sleem, Mark B Effron, Amanda Stebbins, et al.American Heart Journal|June 8, 2023
Comparison of the effectiveness and safety of 2 aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: A subgroup analysis of ADAPTABLEKamal Gupta, Harsh Mehta, Hwasoon Kim, et al.Journal of the American College of Cardiology|April 7, 2022
Trends in Clinical Presentation, Management, and Outcomes of STEMI in Patients With COVID-19Santiago Garcia, Payam Dehghani, Larissa Stanberry, et al.Pageof 15